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Abstract The SH3 domain of Bruton’s tyrosine kinase (Btk) is
preceded by the Tec homology (TH) region containing proline-
rich sequences. We have studied a protein fragment containing
both the Btk SH3 domain and the proline-rich sequences of the
TH region (PRR-SH3). Intermolecular NMR cross-relaxation
measurements, gel permeation chromatography profiles, titra-
tions with proline-rich peptides, and 15N NMR relaxation
measurements are all consistent with a monomer^dimer equili-
brium with a dissociation constant on the order of 60 WM. The
intermolecular interactions do, at least in part, involve proline-
rich sequences in the TH region. This behavior of Btk PRR-SH3
may have implications for the functional action of Btk. ß 2001
Federation of European Biochemical Societies. Published by
Elsevier Science B.V. All rights reserved.
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1. Introduction
Mutations in the gene encoding Bruton’s tyrosine kinase
(Btk) cause the hereditary immunode¢ciency X-linked agam-
maglobulinemia (XLA) [1,2]. Btk belongs to the Tec-family of
non-receptor (cytoplasmic) tyrosine kinases [3]. XLA-causing
mutations have been found in all ¢ve subdomains of Btk [4].
Src homology 3 (SH3) domains interact with proline-rich mo-
tifs with the consensus sequence PXXP [5^7] and this is also
the case for the SH3 domain of Btk [8].
Activation of Btk occurs through phosphorylation of a ty-
rosine in the activation loop of the kinase domain [9] followed
by an autophosphorylation of Y223 within the SH3 domain
[10]. Self-regulation of kinase activity through interaction
involving SH3 domains has been reported for Src-family ki-
nases c-Src and Hck [11,12]. The Tec homology (TH) region
of Btk, located N-terminal to the SH3 domain, contains two
PXXP motifs, whereas the closely related kinases Itk and Bmx
contain only one. For Itk it was shown [13] that the PXXP
motif of the TH region binds intramolecularly to the SH3
domain in a possible self-regulating manner. Here we study
an N-terminally extended fragment of Btk SH3 containing the
proline-rich sequences of the TH region: the PRR-SH3 frag-
ment. We ¢nd that, in contrast to the situation in Itk, the Btk
SH3 domain interacts with the TH region in an intermolecular
manner. This self-association of PRR-SH3 fragments, most
likely in the form of a homodimer, involves binding of a
PXXP motif to the binding pocket of the SH3 domain. We
suggest that the interaction has implications for the activation
of Btk.
2. Materials and methods
2.1. Cloning, expression and puri¢cation
The cloning, expression and puri¢cation of the Btk SH3 domain
have been reported earlier [14]. For the N-terminally extended SH3
(PRR-SH3), the DNA fragment encoding residues 178^275 of human
Btk was ampli¢ed by PCR and the fragment was cloned into the
pGEX-4T-3 vector (Amersham Pharmacia Biotech, Sweden) for ex-
pression in Escherichia coli BL21 (DE3). The expression and puri¢ca-
tion of unlabeled, 15N-labeled, and 13C,15N-labeled Btk PRR-SH3
and SH3 for the present study was essentially carried out as reported
previously [14]. In addition, puri¢ed protein samples were heat-stabi-
lized in Eppendorf tubes at 65‡C for 30 min immediately followed by
cooling to 4‡C and centrifugation at 21 000Ug for 10 min. This pro-
cedure e¡ectively inactivated and removed contaminant proteins. The
mass of PRR-SH3 was con¢rmed using MALDI-TOF mass spectrom-
etry. The protein concentration was measured by absorbance at
278 nm using an extinction coe⁄cient of 18 000 M31 cm31.
2.2. Analytical gel permeation chromatography (GPC)
A Superdex 75 HR 10/30 (Amersham Pharmacia Biotech) column
attached to an Aº KTA puri¢er system, was equilibrated with several
column volumes of phosphate bu¡er. For each run, 0.1 ml of protein
sample was applied to the column. The elution was performed at
0.5 ml min31 and protein absorbance was detected at 280 nm. The
retention behavior was characterized by an average partition coe⁄-
cient cav = (Ve3VM)/VS, where Ve is the elution volume correspond-
ing to the maximum of the elution pro¢le, VM is the void volume of
the mobile phase and VS is the volume available to a totally included
solute. The suitability of the selected column for separation in a mo-
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lecular weight range covering monomer and dimer of PRR-SH3 was
con¢rmed by the elution pro¢le of a Gel Filtration-Low Molecular
Weight Calibration kit standard (Amersham Pharmacia Biotech).
The non-linear retention behavior of PRR-SH3 at various concen-
trations was modeled using the Craig method of propagating the
injected volume through a grid of theoretical plates [15]. The retention
at each plate along the grid was calculated from the e¡ective concen-
tration-dependent partition coe⁄cient for a monomer^dimer equilib-
rium given by ceff =c2+K(c13c2), where c1 and c2 represent parti-
tion coe⁄cients for monomeric and dimeric PRR-SH3, respectively.
The fraction monomers is given by K= Kd [31+(8c0/Kd+1)1=2]/4c0,
where c0 is the total PRR-SH3 concentration (which decreases as
the sample is propagated down the column), and Kd is the dissocia-
tion constant for the dimerization equilibrium. The unknown param-
eters c1, c2, and Kd were estimated by ¢tting cav as a function of
loaded concentrations using unconstrained non-linear least-squares
optimization. The number of plates assumed in the ¢t and the simu-
lation were 900, as this value best reproduced the observed elution
pro¢les.
2.3. Nuclear magnetic resonance (NMR) spectroscopy
NMR was measured at 30 and 45‡C using Varian Inova 500,
Bruker DRX 500 and DRX 600 spectrometers equipped with 5 mm
triple-resonance (1H/15N/13C) probes. Two-dimensional 1H-15N
HSQC and three-dimensional NOESY-HSQC experiments were
carried out and processed using conventional methods [16]. Intermo-
lecular cross-relaxation was detected in two-dimensional F1-13C-ed-
ited,F2-13C,15N-¢ltered NOESY experiments (following the principles
described in [17]) recorded at 45‡C on a sample containing a mixture
of unlabeled and doubly labeled PRR-SH3 at a total concentration of
2.5 mM. The 13C transmitter o¡-set and refocusing delays for the
purge scheme were set to optimize purging of either aliphatic or ar-
omatic 13C-bound proton resonances. The cross-relaxation mixing
time in these experiments was 100 ms.
2.4. Peptide titrations
Peptides corresponding to residues 181^192 of the TH region of Btk
with an additional tyrosine and glutamine residue at the C-terminus
(HRKTKKPLPPTPYQ) were purchased from Ansynth Service B.V.
(Roosendaal, The Netherlands). The peptide used for titration to Btk
SH3 contained a C-terminal amidation which the peptide used for
titration to Btk PRR-SH3 did not contain. The same peptide sequence
was used in a peptide binding study on Btk SH3 [8]. The peptides
were dissolved in phosphate bu¡er at pH 6.5 and their concentrations
were measured by absorbance at 275 nm using the molar extinction
coe⁄cient of tyrosine (1420 M31 cm31). Samples containing 0.6 ml of
0.4 mM 15N-labeled SH3 or PRR-SH3 were prepared in NMR-tubes
and the titrations were performed by adding peptide to the tube and
recording an HSQC spectrum after each addition.
2.5. NMR relaxation measurements
Longitudinal and transverse relaxation rates, R1 and R2, of back-
bone 15N nuclei in well structured regions of the SH3 domain were
measured as reported previously [14]. The overall rotation correlation
time, dc, was estimated from dc = 1/g0(2GR2/R1f)1=2 where g0 is the 15N
Larmor frequency and the GR2/R1f average was measured for
residues in stable secondary structure elements within the SH3 domain
[16].
3. Results
3.1. GPC
In order to investigate the role of SH3 binding sequences
present in the TH region of Btk we ¢rst analyzed the behavior
of the two protein fragments in GPC. The retention of Btk
PRR-SH3 on the GPC column is clearly concentration depen-
dent while that of the Btk SH3 is independent of concentra-
tion (Fig. 1). In addition, the elution pro¢les of PRR-SH3
show clear trailing, whereas those of SH3 (and of other con-
trols) are symmetric. The trailing signi¢es the non-linear re-
tention behavior expected for concentration-dependent self-
association. The peak retention data are consistent with a
monomer^dimer equilibrium with a dissociation constant
Kd = 6U1035 M, as shown in Fig. 2. Simulations also nicely
reproduce the observed asymmetric elution pro¢les for PRR-
SH3 (not shown).
3.2. The NMR spectrum of PRR-SH3 and its concentration
dependence
The di¡erence in NMR chemical shifts between PRR-SH3
and SH3 was analyzed. Sidechain resonances of Y223, M226,
W251, W252, S247, I264 and N267 are among those that have
large chemical shift di¡erences. The backbone resonances of
M228 and N229 in the RT-loop and E245 and S247 in the n-
Src loop are a¡ected, as are those of Y225, W251, W252,
R253, I264, S266, N267 and Y268. These are all within or
close to the proposed poly-proline binding pocket on SH3.
There are also unassigned NOEs involving the structured
SH3 part of PRR-SH3, which are not present in SH3 (not
shown).
A comparison of the HSQC spectrum of PRR-SH3 re-
corded at di¡erent protein concentrations (Fig. 3) with an
HSQC spectrum of SH3 reveals that the di¡erences in back-
bone chemical shifts between PRR-SH3 and SH3 decrease
with the protein concentration. As seen in Fig. 3, the chemical
shift di¡erences for I264 and N267 are signi¢cant at 2 mM,
but small at 0.02 mM. The same is true for nearly all of the
residues that display di¡erent chemical shifts in PRR-SH3 as
compared to the isolated SH3 (not shown) with D232 as the
only exception. The dilution of PRR-SH3 is associated with
sharpening of most backbone amide resonances. The concen-
tration dependence and linewidths as function of concentra-
tion are consistent with a monomeric state of PRR-SH3 at
low concentrations and a dimeric state at higher concentra-
tions.
To prove the existence of intermolecular interactions at
higher concentrations we performed cross-relaxation experi-
ments on a mixture of isotopically labeled and unlabeled
PRR-SH3 at a 2.5 mM total concentration. The experiments
were designed to excite 13C-bound protons and detect only
12C or 14N-bound protons. Cross-relaxation (NOEs) can in
this case only be observed in structured aggregates (dimers)
of labeled and unlabeled protein fragments. Several NOEs
were detected in these experiments, as illustrated in Fig. 4,
which shows intermolecular NOEs between aliphatic and ar-
omatic proton resonances.
Fig. 1. GPC elution pro¢les. A: Btk PRR-SH3 applied at 1.1 mM,
0.8 mM, 0.2 mM, 0.1 mM and 0.05 mM. B: Btk SH3 applied at
0.57, 0.14 and 0.02 mM.
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3.3. Introduction of a SH3 binding sequence from the
TH region as a peptide
To investigate if peptide binding could shift the equilibrium
towards monomeric PRR-SH3 we titrated a TH-peptide (see
Section 2) onto a 15N-labeled sample and monitored changes
in the NMR spectrum. The amide backbone resonances of
Y225, W251, W252, I264 and N267 are signi¢cantly narrower
at 0.25 mM PRR-SH3 with excess TH-peptide compared to
0.3 mM without peptide. In addition, peptide binding has
approximately the same e¡ect on the PRR-SH3 spectrum as
its concentration increases (Fig. 3). These observations are
consistent with breaking a dimer by excess peptide, but intro-
ducing a chemical environment for the involved resonances
which is similar to a fully dimerized sample. In other words,
they link the dimer association behavior of PRR-SH3 to the
TH region. In a control experiment we added TH-peptide to
SH3 and observed the same chemical shifts changes upon
peptide binding to isolated SH3, as expected.
3.4. Rotation correlation time
In a ¢nal set of experiments we used 15N relaxation data to
estimate the rotation correlation time, dc, for Btk PRR-SH3
to 11 ns (at 2 mM). A comparison with the value previously
reported for monomeric Btk SH3 (5.5 ns) again supports a
monomer^dimer equilibrium in PRR-SH3 samples.
4. Discussion
Self-regulation of non-receptor kinases through intramolec-
ular interactions has been reported for several kinases
[11,12,18,19]. For the SH3 domain of the Tec-family kinase
Itk it has been shown that a SH3 binding sequence in an N-
terminal extension binds in an intramolecular fashion to the
binding pocket of the SH3 domain [13]. Here we ¢nd that this
is not the case for Btk SH3. Instead, GPC elution pro¢les,
intermolecular NMR cross-relaxation and 15N NMR relaxa-
tion measurements are consistent with a monomer^dimer
equilibrium with a dissociation constant on the order of 60
WM. In addition, comparison of chemical shifts and resonance
linewidths as a function of concentration with those observed
in TH-peptide titrations indicate that peptide binding com-
petes with dimerization. Based on these results we conclude
that the interaction between the TH region and the SH3 do-
main is intermolecular rather than intramolecular in protein
fragments containing both the TH region and SH3 domain of
Btk.
It has been shown that the autophosphorylation of Y223
within the SH3 domain regulates the kinase activity in vivo
[13]. In in vitro experiments, active full-length Btk is able to
phosphorylate recombinant Btk SH3 domain at Y223. Thus,
full-length Btk can interact with its own SH3 domain through
protein^protein interactions. Our experiments suggest how
this interaction may occur. Dimerization of receptor tyrosine
kinases and activation through trans-phosphorylation of tyro-
sines is known for some growth factor receptors e.g. the plate-
Fig. 2. Quantitative analysis of the concentration dependence of Btk
PRR-SH3 elution from the GPC column. The observed average par-
tition coe⁄cient, cav, is plotted as function of the concentration of
the applied sample. The solid line represents a ¢t of the data to a
monomer^dimer equilibrium model with a dissociation constant Kd
of 60 WM.
Fig. 3. Section of the 15N HSQC NMR spectrum of Btk PRR-SH3
and Btk SH3 samples. Backbone amide assignments have been indi-
cated. The resonances of I264 and N267 under di¡erent conditions
are annotated as follows, a: Btk SH3 reference; b^d: Btk PRR-SH3
at 0.02, 0.3 and 2 mM concentrations, respectively, and e: 0.25 mM
PRR-SH3 with 5 mM TH-peptide.
Fig. 4. Section of a F1-13C-edited,F2-13C,15N-¢ltered NOESY ex-
periment recorded on a mixture of unlabeled and doubly labeled
PRR-SH3 at a total concentration of 2.5 mM. The experiment was
optimized for editing of 13C-bound aliphatic protons in F1 and ¢l-
tering of 13C-bound aromatic and 15N-bound proton resonances in
F2. The dashed lines connect NOEs with identical chemical shifts in
F1 or F2.
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let-derived growth factor receptor [20]. Also, dimerization via
SH3 domains has been reported for the p85alpha regulatory
subunit of phosphatidylinositol-3 kinase [21]. The observed
self-association of PRR-SH3 opens up for the possibility
that the autophosphorylation event in activation of Btk oc-
curs in trans rather than in cis. Another possibility is that the
phosphorylation destabilizes a pre-formed Btk dimer. Both
these scenarios may have implications for the understanding
of Btk activation.
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